Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes

NCT00898950 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: Aspirin
DRUG: Aspirin
DRUG: Aspirin
OTHER: placebo tablet

Sponsor

University of Portsmouth